HIV and cancer: study seeks to uncover hidden risk factors
NCT ID NCT07696169
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This study looks at how certain cancers develop in people with HIV and what factors might increase their risk. Researchers will analyze medical data from 1,000 HIV-positive adults to track which types of cancer occur most often and why. The goal is to improve early detection and care for these cancers, but no experimental treatments are involved.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify HIV patients at higher risk for certain cancers earlier, potentially leading to better screening and prevention strategies.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. The findings may not apply to all HIV populations or lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AIDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who will survive a bowel surgery leak?
- Can a Two-Drug attack shrink Hard-to-Treat colorectal tumors?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Can a cancer drug reboot the immune system after a stem cell transplant?
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- Could a genetic marker guide future cancer therapies in taiwan?